Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss, Neurology, Psychiatric, Endocrine |
| Therapuetic Areas: | Endocrinology, Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | December 2009 |
| End Date: | May 2012 |
| Contact: | Nilda Itchon-Ramos |
| Email: | nilda.itchonramos@duke.edu |
| Phone: | 919-416-2083 |
Vyvanse and Glucose Intolerance in Children With ADHD and Obesity
The purpose of this study to assess the effects of chronic administration of Vyvanse
(lis-dexamphetamine) on glucose metabolism in a sample of children and adolescents with
Attention Deficit Hyperactivity Disorder (ADHD) who also have glucose intolerance and are
obese.
Inclusion Criteria:
- male or female, ages between 8 and 17
- Body Mass Index > 30
- fasting blood sugar between 90-100 mg/dl
- 2 hour post prandial >140 <180 mg/dl
- meets criteria for a diagnosis of ADHD, any subtype
Exclusion Criteria:
- known cardiovascular disease or diabetes
- structural cardiac abnormalities, abnormal ECGs, family history of sudden death
- positive urine drug screen
- fasting blood sugar level > 126 mg/dl
- HbA1c > 6.5 %
- Weight > 300 lbs
We found this trial at
1
site
Click here to add this to my saved trials
